Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-15-010911
Filing Date
2015-06-16
Accepted
2015-06-16 13:42:06
Documents
1
Effectiveness Date
2015-06-16

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-15-010911.paper CERTNAS 294
  Scanned paper document scanned.pdf   446233
  Complete submission text file 9999999997-15-010911.txt   1400
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-37449 | Film No.: 15007775
SIC: 2834 Pharmaceutical Preparations